Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Monthly Archives: January 2011

Home/2011/January
31 01, 2011

New Lymphoma Drug, Zinapar, Gets Gains Orphan Drug Status In Europe

0 Comments

Just because my site is named, CancerNews.US, doesn't mean we only cover American cancer news.  Often the United States is out-in-front of the world in oncology practice and research.  But sometimes Europe or Japan leads the way.  Here is a good example of this:Ziopharm says lymphoma drug may get EU incentivesJan 20, 2011 By The Associated Press NEW YORK

29 01, 2011

OncologySTAT Posts Abstract Confirming Chemo Brain Is Real

0 Comments

Either Called "Chemobrain" or "Chemofog," the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is RealJ Pain Symptom Manage. 2011 Jan 1;41(1):126-139, AA Argyriou, K Assimakopoulos, G Iconomou, F Giannakopoulou, HP KalofonosAbstractContext: In recent years, there is growing evidence in the medical literature to support an association between administration of commonly used chemotherapeutic agents and an

29 01, 2011

Multiple Myeloma Patients Take Note: Celgene Shares Their Company Goals For 2011

Tags: , , , |0 Comments

Wednesday I shared a few specifics from Celgene Corporation's 2010 annual report.  You can read the company's entire press release by going to Myeloma News.com and clicking on: CELGENE REPORTS RECORD FOURTH QUARTER AND FULL YEAR 2010 OPERATING AND FINANCIAL RESULTS.Note how much progress the company is making finding cross-over markets for Revlimid and the yet to be

28 01, 2011

More About Roche Pharmaceutical’s New Melanoma Drug, RG7204

0 Comments

Experimental Melanoma Drug May Help Extend Patients' LivesBy Samantha Rollins - Friday, January 21, 2011 Malignant melanoma of the diffuse large non-cleaved cell type. Note the large cells with nucleoli and mitotic stages. H&E stain, LM X160.The results of a promising recent clinical trial showed that an experimental drug prolonged life in patients with melanoma, the

28 01, 2011

Removing FDA Required Testing Prior To Non-Hodgkin’s Lymphoma Therapy Should Save Patients Time & Money:

0 Comments

Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN® ZEVALIN® is Currently Approved By The FDA and Marketed by Spectrum Pharmaceuticals in the United States For: Treatment of Patients With Previously Untreated Follicular Non-Hodgkin’s Lymphoma (NHL), Who Achieve a Partial or Complete Response to First-Line Chemotherapy Treatment of Patients with Relapsed

27 01, 2011

Celgene’s Global Revlimid Sales Total $2.47 Billion In 2010 – Up 45%

Tags: , , , |2 Comments

Celgene Corporation, makers of the oral, anti-myeloma chemotherapy agent, Revlimid, announced their 4th quarter and full-year financials this morning. I'm not going to post all of the data here.  But several parts of the report should interest my fellow multiple myeloma patients:For the 4th quarter, Total Revenue Increased 38 Percent to $1.07 BillionGlobal REVLIMID® Net

26 01, 2011

CNN Opinion Page: Do we really want or need to detect cancer earlier?

0 Comments

Cancer breakthrough -- or nightmare?By H. Gilbert Welch, Special to CNN January 11, 2011 9:15 a.m. EST STORY HIGHLIGHTSDr. H. Gilbert Welch: New test is said to detect a single cancer cell in blood He says there's a downside to ever more precise cancer screening Tests can detect cancer that may never harm or kill

26 01, 2011

Breast Cancer and Diabetes Don’t Mix

0 Comments

Here is an unfortunate article I found on FoxNews.com last week:Women's HealthDiabetics Diagnosed With Breast Cancer 50 Percent More Likely to DiePublished January 18, 2011 - | FoxNews.comAP PhotoWomen who have been diagnosed with breast cancer are nearly 50 percent more likely to die from any cause if they have diabetes, according to a study

26 01, 2011

Insightful Newspaper Article About Pomalidomide/Biaxin/Dex Clinical Study In New York City

Tags: , , , , |2 Comments

Here is an interesting article I found in the Cornell Daily Sun this morning.  Interesting because it is combines basics with a very insightful look at a promising clinical trial featuring pomalidomide:Weill Develops Alternative Cancer TreatmentJanuary 26, 2011 By Maria Minsker For patients suffering from cancer, learning their body is resistant to traditional therapy can

25 01, 2011

Eating Soy Could Also Help Slow Prostate Cancer Growth

0 Comments

Did you read the the previous article I posted earlier today?  Best I can tell, all a guy with prostate cancer needs to do to is exercise a lot and eat plenty of soy!  Private MD Labs.com featured this story on their Website earlier this month:Private MD NewsSoy may slow the growth of prostate cancer

25 01, 2011

Men With Prostate Cancer Live Longer When They Exercise!

0 Comments

Exercise May Improve Odds Against Prostate Cancer DeathStudy found three hours or more of vigorous activity a week upped patients' long-term survivalBy Alan MozesHealthDay ReporterWEDNESDAY, Jan. 5 (HealthDay News) -- Prostate cancer patients who routinely engage in modest amounts of vigorous physical exercise appear to lower their risk of dying from their disease, new research

25 01, 2011

I Just Finished My First Day As A Caregiver Again…

Tags: , |6 Comments

As my regular readers probably know, my wife Pattie is a three time cancer survivor.  She had three different cancers--all before my diagnosis around four years ago.No--my wife doesn't have cancer again, thank God!  But our adopted "son," Finnegan does.  Finnegan is an eight year English pointer mix.  A shelter dog, we saved Finn from